First Financial Corp’s Pfizer PFE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$246K Sell
10,210
-100
-1% -$2.62K 0.09% 116
2026
Q1
$290K Buy
10,310
+100
+1% +$2.66K 0.11% 106
2025
Q4
$254K Hold
10,210
0.1% 115
2025
Q3
$260K Sell
10,210
-969
-9% -$23.9K 0.1% 114
2025
Q2
$271K Sell
11,179
-1,448
-11% -$33.8K 0.12% 102
2025
Q1
$320K Sell
12,627
-925
-7% -$24.2K 0.15% 96
2024
Q4
$360K Sell
13,552
-568
-4% -$15.4K 0.17% 90
2024
Q3
$409K Buy
14,120
+1,470
+12% +$42.9K 0.2% 91
2024
Q2
$354K Sell
12,650
-785
-6% -$21.6K 0.18% 91
2024
Q1
$373K Sell
13,435
-2,074
-13% -$57.5K 0.19% 90
2023
Q4
$446K Sell
15,509
-17
-0.1% -$514 0.23% 84
2023
Q3
$515K Sell
15,526
-154
-1% -$5.45K 0.3% 70
2023
Q2
$575K Sell
15,680
-400
-2% -$15.6K 0.37% 59
2023
Q1
$656K Sell
16,080
-467
-3% -$20.2K 0.41% 52
2022
Q4
$848K Sell
16,547
-1,083
-6% -$51.9K 0.52% 44
2022
Q3
$772K Buy
17,630
+2,400
+16% +$117K 0.52% 44
2022
Q2
$798K Sell
15,230
-48
-0.3% -$2.45K 0.53% 44
2022
Q1
$791K Sell
15,278
-28
-0.2% -$1.45K 0.48% 48
2021
Q4
$903K Sell
15,306
-4,872
-24% -$241K 0.55% 38
2021
Q3
$867K Sell
20,178
-350
-2% -$15.5K 0.58% 37
2021
Q2
$803K Buy
20,528
+1,085
+6% +$42.2K 0.53% 42
2021
Q1
$704K Sell
19,443
-3,690
-16% -$131K 0.49% 45
2020
Q4
$852K Sell
23,133
-2,559
-10% -$93.9K 0.63% 37
2020
Q3
$895K Buy
25,692
+1,017
+4% +$35.7K 0.76% 31
2020
Q2
$766K Sell
24,675
-1,126
-4% -$38.3K 0.65% 35
2020
Q1
$799K Buy
25,801
+681
+3% +$23.2K 0.73% 28
2019
Q4
$934K Sell
25,120
-758
-3% -$27K 0.68% 26
2019
Q3
$882K Buy
25,878
+791
+3% +$28.8K 0.69% 30
2019
Q2
$1.03M Sell
25,087
-23,930
-49% -$950K 0.83% 23
2019
Q1
$1.98M Sell
49,017
-222
-0.5% -$8.89K 1.47% 12
2018
Q4
$2.04M Sell
49,239
-2,182
-4% -$90.6K 1.64% 11
2018
Q3
$2.15M Sell
51,421
-636
-1% -$24.5K 1.41% 11
2018
Q2
$1.79M Hold
52,057
1.25% 13
2018
Q1
$1.75M Sell
52,057
-2,760
-5% -$94.9K 1.26% 12
2017
Q4
$1.88M Sell
54,817
-4,443
-7% -$151K 1.22% 13
2017
Q3
$2.01M Sell
59,260
-2,779
-4% -$89.3K 1.31% 12
2017
Q2
$1.98M Sell
62,039
-1,363
-2% -$43K 1.26% 11
2017
Q1
$2.06M Buy
63,402
+21,090
+50% +$665K 1.31% 13
2016
Q4
$1.3M Sell
42,312
-2,069
-5% -$63.2K 0.78% 25
2016
Q3
$1.43M Sell
44,381
-4,555
-9% -$152K 0.84% 22
2016
Q2
$1.63M Sell
48,936
-32,610
-40% -$1.04M 0.95% 19
2016
Q1
$2.29M Sell
81,546
-1,584
-2% -$45.2K 1.2% 13
2015
Q4
$2.55M Buy
83,130
+2,740
+3% +$86.2K 1.35% 10
2015
Q3
$2.4M Buy
80,390
+4,446
+6% +$143K 1.35% 9
2015
Q2
$2.42M Sell
75,944
-3,900
-5% -$127K 1.22% 10
2015
Q1
$2.64M Buy
79,844
+580
+0.7% +$18.4K 1.33% 9
2014
Q4
$2.34M Sell
79,264
-2,872
-3% -$82.3K 1.17% 11
2014
Q3
$2.3M Buy
82,136
+4,479
+6% +$126K 1.14% 11
2014
Q2
$2.19M Buy
77,657
+2,065
+3% +$58.9K 1.05% 14
2014
Q1
$2.3M Buy
75,592
+2,009
+3% +$59.9K 1.11% 12
2013
Q4
$2.14M Buy
73,583
+15,863
+27% +$462K 1% 13
2013
Q3
$1.57M Sell
57,720
-4,246
-7% -$116K 0.77% 21
2013
Q2
$1.65M Buy
+61,966
New +$1.71M 0.82% 21

Other funds holding PFE

First Financial Corp's PFE Position: Q2 2026 in Review

First Financial Corp reduced its Pfizer (PFE) stake by 0.97% in Q2 2026, selling an estimated $2.62K and leaving 10,210 shares worth $246K. The position accounts for 0.09% of the portfolio, ranked #116.

First Financial Corp first reported a position in PFE in Q2 2013 and has held it in 53 quarters since. The position peaked at $2.64M in Q1 2015. 719 funds tracked by Wall St. Rank hold PFE as of Q2 2026.

  • First Financial Corp held 10,210 shares of Pfizer worth $246K as of Q2 2026.
  • First Financial Corp sold 100 Pfizer shares in Q2 2026, an estimated $2.62K.
  • Pfizer made up 0.09% of First Financial Corp's portfolio in Q2 2026, its #116 holding.
  • First Financial Corp first reported a position in Pfizer in Q2 2013 and has held it in 53 quarters since.
  • First Financial Corp's Pfizer position peaked at $2.64M in Q1 2015.
  • 719 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.

Based on First Financial Corp's 13F filing for Q2 2026, filed 7 Jul 2026.